The St. Petersburg facility is North America's primary softgel development and manufacturing site, equipped with a dedicated pilot plant for lipid formulation development and rapid transition from lab scale to clinical supply. It also offers liquid-in-bottle and liquid-fill hard-shell capabilities to expedite speed to clinic. Within the Catalent network, the site provides integrated formulation and analytical services to address complex development and manufacturing challenges. The analytical laboratory offers comprehensive services, from method development to routine QC testing, supporting commercial and development stability studies. With an annual capacity of over 18 billion softgels and serving over 100 global markets, the St. Petersburg site can handle manufacturing needs for Over the Counter (OTC), Prescription (Rx), Medical Device, Controlled Substance, or Dietary Supplement products. The facility includes a segregated hormone manufacturing area compliant with current regulatory requirements. In addition to traditional animal-based gelatin softgels, the site produces products in non-gelatin based OptiShell® and Vegicaps® to broaden the range of encapsulatable molecules.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level